Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Othus

Showing results (41-50 of 231) with videos related to

Pageof 24
Sort By:
Gynecologic Oncology|January 11, 2024
Prognosis and conditional survival among women with newly diagnosed ovarian cancerElizabeth A Szamreta, Matthew J Monberg, Kaushal D Desai, et al.
Cancer|September 8, 2017
Quality of life from the perspective of the patient with acute myeloid leukemiaSarah A Buckley, Diana Jimenez-Sahagun, Megan Othus, et al.
Leukemia & Lymphoma|December 24, 2015
Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?Daisuke Araki, Megan Othus, Roland B Walter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2018
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AMLYi Zhou, Megan Othus, Roland B Walter, et al.
JCO Oncology Advances|December 8, 2025
Outcomes of Patients with Rare Cancers Treated with Combination Immune Checkpoint Inhibitors With and Without Prior anti-PD-1/L1 Exposure (NCI/SWOG S1609)Megan Othus, Sandip P Patel, Young Kwan Chae, et al.
Haematologica|February 19, 2011
Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotypeBin Xie, Megan Othus, Bruno C Medeiros, et al.
Bone Marrow Transplantation|February 17, 2025
Modulators of relapse risk in adults allografted for acute myeloid leukemia in measurable residual disease-positive remissionMargery Gang, Megan Othus, Brenda M Sandmaier, et al.
Clinical Trials (London, England)|March 18, 2025
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)Megan Othus, Elad Sharon, Michael C Wu, et al.
Leukemia|June 6, 2022
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemiaCorentin Orvain, Megan Othus, Gurleen Johal, et al.
Leukemia & Lymphoma|March 12, 2019
Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasmsSarah A Buckley, Nicholas M Mark, Megan Othus, et al.
Pageof 24

Showing results (41-50 of 231) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology|January 11, 2024
Prognosis and conditional survival among women with newly diagnosed ovarian cancerElizabeth A Szamreta, Matthew J Monberg, Kaushal D Desai, et al.
Cancer|September 8, 2017
Quality of life from the perspective of the patient with acute myeloid leukemiaSarah A Buckley, Diana Jimenez-Sahagun, Megan Othus, et al.
Leukemia & Lymphoma|December 24, 2015
Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?Daisuke Araki, Megan Othus, Roland B Walter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2018
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AMLYi Zhou, Megan Othus, Roland B Walter, et al.
JCO Oncology Advances|December 8, 2025
Outcomes of Patients with Rare Cancers Treated with Combination Immune Checkpoint Inhibitors With and Without Prior anti-PD-1/L1 Exposure (NCI/SWOG S1609)Megan Othus, Sandip P Patel, Young Kwan Chae, et al.
Haematologica|February 19, 2011
Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotypeBin Xie, Megan Othus, Bruno C Medeiros, et al.
Bone Marrow Transplantation|February 17, 2025
Modulators of relapse risk in adults allografted for acute myeloid leukemia in measurable residual disease-positive remissionMargery Gang, Megan Othus, Brenda M Sandmaier, et al.
Clinical Trials (London, England)|March 18, 2025
Design considerations for randomized comparisons of neoadjuvant-adjuvant versus adjuvant-only cancer immunotherapy when tumor measurement schedules do not align (SWOG S1801)Megan Othus, Elad Sharon, Michael C Wu, et al.
Leukemia|June 6, 2022
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemiaCorentin Orvain, Megan Othus, Gurleen Johal, et al.
Leukemia & Lymphoma|March 12, 2019
Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasmsSarah A Buckley, Nicholas M Mark, Megan Othus, et al.
Pageof 24